sales@fnfresearch.comTel: +86 21 80360450 | USA: +1-347-989-3985

Search Market Research Report

Home / Healthcare / Ophthalmic Drug

Ophthalmic Drug Market By Type (Over-the-Counter Drugs and Prescription Drugs), By Drug Class (Anti-inflammatory Drugs, Anti-Infective Drugs, Anti-Allergic Drugs, Anti-Glaucoma Drugs, and Others), By Disease Indication (Inflammation/ Infection, Retinal Disorders, Dry Eye, Glaucoma, Allergies, and Others), By Distribution Channel (Online Sales, Retail Pharmacies, Hospital Pharmacies, and Others), and By Region: Global Industry Perspective, Market Size, Statistical Research, Market Intelligence, Comprehensive Analysis, Historical Trends, and Forecasts, 2019–2026

  • Publish On: Feb-2020
  • Total Pages: 110
  • Report Code: FAF-448
  • Base Year: 2019
  • Format:

Industry Insights

This professional and specialized report study examines the technical and business perspective of the global ophthalmic drug industry. The report provides a historical analysis of the industry as well as the projected trends expected to be witnessed in the global ophthalmic drug market. The report study analyzes the market statistics at the global as well as the regional levels to gain an in-depth perspective of the overall global ophthalmic drug market. The historical insights are provided from 2016 to 2019 and projected trends are provided from 2020 to 2026. The quantitative data is provided in terms of both volume (K Units) and value (USD Million) for 2016 – 2026. The qualitative data is reinforced by analyzing and providing numerous market dynamics (directly or indirectly affecting the industry) such as growth drivers, restraints, challenges, and opportunities.

We have included various industry analysis models in our report and extensively demonstrated the key business strategies and competitive landscape of the global ophthalmic drug market in our study.

Our study also includes an analysis of Porter’s Five Forces framework for understanding the competitive strategies adopted by various stakeholders involved in the entire value chain of the global ophthalmic drug market. It also encompasses PESTLE analysis and SWOT analysis.

The report also offers an in-depth analysis of the market shares of each industry player and gives an outline of the market position of key players in the global ophthalmic drug market. Moreover, the study offers wide coverage of key strategic advances witnessed in the market such as new product launches, acquisitions & mergers, collaborations & joint ventures, funding & VC activities, agreements, partnerships, R&D activities, and regional expansion of key players of the global ophthalmic drug market.

The research study provides a critical assessment of the global ophthalmic drug industry by logically segmenting the market on the basis of type, drug class, disease indication, distribution channel, and regions. Based on the past, present, and future trends, all the segments were analyzed from the bottom up, and the market sizes have been estimated from 2020 to 2026. The regional segmentation of the global ophthalmic drug industry includes the holistic bifurcation of all the five major continents including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

The visual impairment incidences have been surging considerably worldwide irrespective of the age group. This challenging situation has urged drug manufacturers and pharmaceutical companies to design and supply effective medications against this rapidly spreading disorder. Hence, the introduction of novel effective ophthalmic drug bolsters the global ophthalmic drug market. Exposure to air and water pollution poses a greater risk to the eyes. Thus, surging the demand for the drugs and propelling the global ophthalmic drug market.

The global ophthalmic drug market is segmented based on type, drug class, disease indication, distribution channel, and region. By type, the market is segmented into over-the-counter drugs and prescription drugs. Drug class classifies the market into anti-inflammatory drugs, anti-infective drugs, anti-allergic drugs, anti-glaucoma drugs, and others. Based on disease indication, the global market is categorized into inflammation/ infection, retinal disorders, dry eye, glaucoma, allergies, and others. The distribution channel segment of the global magnesium chloride market is sectored into online sales, retail pharmacies, hospital pharmacies, and others.

Some of the essential players operating in the global ophthalmic drug market, but not restricted to includeSanten Pharmaceutical Co. Ltd., Bayer AG, ALLERGAN, Novartis AG, Pfizer Inc., Genentech Inc., Oxurion NV, Bausch Health Companies Inc., and Regeneron Pharmaceuticals Inc., among others.

The global ophthalmic drug market is segmented as:

Global Ophthalmic Drug Market: Type Segmentation Analysis

  • Over-the-Counter Drugs
  • Prescription Drugs

Global Ophthalmic Drug Market: Drug Class Segmentation Analysis

  • Anti-Infective Drugs
    • Anti-Bacterial Drugs
    • Anti-Fungal Drugs
    • Anti-Viral Drugs
    • Others
  • Anti-Glaucoma Drugs
    • Prostaglandin Analogs
    • Alpha Agonist
    • BetaBlockers
    • Combined Medication
    • Others
  • Anti-inflammatory Drugs
    • Steroids
    • Non-Steroidal Anti-Inflammatory Drugs
  • Anti-Allergic Drugs
  • Others

Global Ophthalmic Drug Market: Disease Indication Segmentation Analysis

  • Inflammation/ Infection
  • Retinal Disorders
  • Dry Eye
  • Glaucoma
  • Allergies
  • Others

Global Ophthalmic Drug Market: Distribution Channel Segmentation Analysis

  • Online Sales
  • Retail Pharmacies
  • Hospital Pharmacies
  • Others

Global Ophthalmic Drug Market: Regional Segmentation Analysis

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

KEY BUSINESS POINTERS ADDRESSED & FOREMOST REASONS TO PROCURE THE REPORT:

  • Statistical Analysis of the Past, Current, and Future Trends of the Industry with Validated Market Sizes Data
  • Direct and Indirect Rationales Impacting the Industry
  • In-depth and Micro Analysis of Viable Segments and Sub-segments
  • Companies and Vendors Market Share, Competitive Landscape, and Player Positioning Analysis
  • Demand Side (Consumption) and Supply Side (Production) Perspective and Analysis wherever applicable
  • Key Buyers and End-Users Analysis
  • Value Chain and Manufacturing Cost Structure Analysis wherever relevant
  • Key Marketing Strategies as well as Key Sales Channels adopted in the market
  • Investment Opportunity Analysis & Patents Analysis wherever feasible
  • Technological Road Map & Technical Analysis
  • Robust Research Methodology comprising dynamic mix (65%~35%) of Extensive Primary Research (primary interviews, ad-hoc surveys, questionnaires) and Protracted Secondary Research (proprietary in-house database, paid external databases, publically available validated sources)

Table of Content

  1. CHAPTER 1. Executive Summary 25
  2. CHAPTER 2. Ophthalmic drug market – Type Analysis 27
    1. 2.1. Global Ophthalmic drug Market – Type Overview 27
    2. 2.2. Global Ophthalmic drug Market Share, by Type, 2018 & 2025 (USD Million) 27
    3. 2.3. Global Ophthalmic drug Market share, by Type, 2018 & 2025 (K Units) 29
    4. 2.4. Over-the-Counter Drugs 30
      1. 2.4.1. Global Over-the-Counter Drugs Ophthalmic drug Market, 2016-2026 (USD Million) 30
      2. 2.4.2. Global Over-the-Counter Drugs Ophthalmic drug Market, 2016-2026 (K Units) 31
    5. 2.5. Prescription Drugs 32
      1. 2.5.1. Global Prescription Drugs Ophthalmic drug Market, 2016-2026 (USD Million) 32
      2. 2.5.2. Global Prescription Drugs Ophthalmic drug Market, 2016-2026 (K Units) 33
  3. CHAPTER 3. Ophthalmic drug market – Drug Class Analysis 33
    1. 3.1. Global Ophthalmic drug Market – Drug Class Overview 33
    2. 3.2. Global Ophthalmic drug Market Share, by Drug Class, 2018 & 2025 (USD Million) 33
    3. 3.3. Global Ophthalmic drug Market share, by Drug Class, 2018 & 2025 (K Units) 35
    4. 3.4. Anti-Infective Drugs 36
      1. 3.4.1. Global Anti-Infective Drugs Ophthalmic drug Market, 2016-2026 (USD Million) 36
      2. 3.4.2. Global Anti-Infective Drugs Ophthalmic drug Market, 2016-2026 (K Units) 37
    5. 3.5. Anti-Glaucoma Drugs 38
      1. 3.5.1. Global Anti-Glaucoma Drugs Ophthalmic drug Market, 2016-2026 (USD Million) 38
      2. 3.5.2. Global Anti-Glaucoma Drugs Ophthalmic drug Market, 2016-2026 (K Units) 39
    6. 3.6. Anti-inflammatory Drugs 40
      1. 3.6.1. Global Anti-inflammatory Drugs Ophthalmic drug Market, 2016-2026 (USD Million) 40
      2. 3.6.2. Global Anti-inflammatory Drugs Ophthalmic drug Market, 2016-2026 (K Units) 41
    7. 3.7. Anti-Allergic Drugs 42
      1. 3.7.1. Global Anti-Allergic Drugs Ophthalmic drug Market, 2016-2026 (USD Million) 42
      2. 3.7.2. Global Anti-Allergic Drugs Ophthalmic drug Market, 2016-2026 (K Units) 43
  4. CHAPTER 4. Ophthalmic drug market – Disease Indication Analysis 43
    1. 4.1. Global Ophthalmic drug Market – Disease Indication Overview 43
    2. 4.2. Global Ophthalmic drug Market Share, by Disease Indication, 2018 & 2025 (USD Million) 43
    3. 4.3. Global Ophthalmic drug Market share, by Disease Indication, 2018 & 2025 (K Units) 45
    4. 4.4. Inflammation/ Infection 46
      1. 4.4.1. Global Inflammation/ Infection Ophthalmic drug Market, 2016-2026 (USD Million) 46
      2. 4.4.2. Global Inflammation/ Infection Ophthalmic drug Market, 2016-2026 (K Units) 47
    5. 4.5. Retinal Disorders 48
      1. 4.5.1. Global Retinal Disorders Ophthalmic drug Market, 2016-2026 (USD Million) 48
      2. 4.5.2. Global Retinal Disorders Ophthalmic drug Market, 2016-2026 (K Units) 49
    6. 4.6. Dry Eye 50
      1. 4.6.1. Global Dry Eye Ophthalmic drug Market, 2016-2026 (USD Million) 50
      2. 4.6.2. Global Dry Eye Ophthalmic drug Market, 2016-2026 (K Units) 51
    7. 4.7. Glaucoma 52
      1. 4.7.1. Global Glaucoma Ophthalmic drug Market, 2016-2026 (USD Million) 52
      2. 4.7.2. Global Glaucoma Ophthalmic drug Market, 2016-2026 (K Units) 53
    8. 4.8. Allergies 54
      1. 4.8.1. Global Allergies Ophthalmic drug Market, 2016-2026 (USD Million) 54
      2. 4.8.2. Global Allergies Ophthalmic drug Market, 2016-2026 (K Units) 55
    9. 4.9. Others 56
      1. 4.9.1. Global Others Ophthalmic drug Market, 2016-2026 (USD Million) 56
      2. 4.9.2. Global Others Ophthalmic drug Market, 2016-2026 (K Units) 57
  5. CHAPTER 5. Ophthalmic drug market – Distribution Channel Analysis 57
    1. 5.1. Global Ophthalmic drug Market – Distribution Channel Overview 57
    2. 5.2. Global Ophthalmic drug Market Share, by Distribution Channel, 2018 & 2025 (USD Million) 57
    3. 5.3. Global Ophthalmic drug Market share, by Distribution Channel, 2018 & 2025 (K Units) 59
    4. 5.4. Online Sales 60
      1. 5.4.1. Global Online Sales Ophthalmic drug Market, 2016-2026 (USD Million) 60
      2. 5.4.2. Global Online Sales Ophthalmic drug Market, 2016-2026 (K Units) 61
    5. 5.5. Retail Pharmacies 62
      1. 5.5.1. Global Retail Pharmacies Ophthalmic drug Market, 2016-2026 (USD Million) 62
      2. 5.5.2. Global Retail Pharmacies Ophthalmic drug Market, 2016-2026 (K Units) 63
    6. 5.6. Hospital Pharmacies 64
      1. 5.6.1. Global Hospital Pharmacies Ophthalmic drug Market, 2016-2026 (USD Million) 64
      2. 5.6.2. Global Hospital Pharmacies Ophthalmic drug Market, 2016-2026 (K Units) 65
    7. 5.7. Others 66
      1. 5.7.1. Global Others Ophthalmic drug Market, 2016-2026 (USD Million) 66
      2. 5.7.2. Global Others Ophthalmic drug Market, 2016-2026 (K Units) 67
  6. CHAPTER 6. Ophthalmic drug market – Regional Analysis 68
    1. 6.1. Global Ophthalmic drug Market Regional Overview 68
    2. 6.2. Global Ophthalmic drug Market Share, by Region, 2018 & 2025 (Value) 68
    3. 6.3. Global Ophthalmic drug Market Share, by Region, 2018 & 2025 (Volume) 70
    4. 6.4. North America 71
      1. 6.4.1. North America Ophthalmic drug Market size and forecast, 2016-2026 71
      2. 6.4.2. North America Ophthalmic drug Market, by Country, 2018 - 2025 (USD Million) 71
      3. 6.4.3. North America Market size and forecast, 2016-2026 (K Units) 72
      4. 6.4.4. North America Ophthalmic drug Market, by Country, 2018 - 2025 (K Units) 72
      5. 6.4.5. North America Ophthalmic drug Market, by Type, 2016-2026 73
        1. 6.4.5.1. North America Ophthalmic drug Market, by Type, 2016-2026 (USD Million) 73
        2. 6.4.5.2. North America Ophthalmic drug Market, by Type, 2016-2026 (K Units) 73
      6. 6.4.6. North America Ophthalmic drug Market, by Drug Class, 2016-2026 74
        1. 6.4.6.1. North America Ophthalmic drug Market, by Drug Class, 2016-2026 (USD Million) 74
        2. 6.4.6.2. North America Ophthalmic drug Market, by Drug Class, 2016-2026 (K Units) 74
      7. 6.4.7. North America Ophthalmic drug Market, by Disease Indication, 2016-2026 75
        1. 6.4.7.1. North America Ophthalmic drug Market, by Disease Indication, 2016-2026 (USD Million) 75
        2. 6.4.7.2. North America Ophthalmic drug Market, by Disease Indication, 2016-2026 (K Units) 75
      8. 6.4.8. North America Ophthalmic drug Market, by Distribution Channel, 2016-2026 77
        1. 6.4.8.1. North America Ophthalmic drug Market, by Distribution Channel, 2016-2026 (USD Million) 77
        2. 6.4.8.2. North America Ophthalmic drug Market, by Distribution Channel, 2016-2026 (K Units) 77
      9. 6.4.9. U.S. 79
        1. 6.4.9.1. U.S. Market size and forecast, 2016-2026 (USD Million) 79
        2. 6.4.9.2. U.S. Market size and forecast, 2016-2026 (K Units) 80
      10. 6.4.10. Canada 81
        1. 6.4.10.1. Canada Market size and forecast, 2016-2026 (USD Million) 81
        2. 6.4.10.2. Canada Market size and forecast, 2016-2026 (K Units) 82
    5. 6.5. Europe 83
      1. 6.5.1. Europe Ophthalmic drug Market size and forecast, 2016-2026 83
      2. 6.5.2. Europe Ophthalmic drug Market, by Country, 2018 - 2025 (USD Million) 83
      3. 6.5.3. Europe Market size and forecast, 2016-2026 (K Units) 85
      4. 6.5.4. Europe Ophthalmic drug Market, by Country, 2018 - 2025 (K Units) 85
      5. 6.5.5. Europe Ophthalmic drug Market, by Type, 2016-2026 87
        1. 6.5.5.1. Europe Ophthalmic drug Market, by Type, 2016-2026 (USD Million) 87
        2. 6.5.5.2. Europe Ophthalmic drug Market, by Type, 2016-2026 (K Units) 87
      6. 6.5.6. Europe Ophthalmic drug Market, by Drug Class, 2016-2026 88
        1. 6.5.6.1. Europe Ophthalmic drug Market, by Drug Class, 2016-2026 (USD Million) 88
        2. 6.5.6.2. Europe Ophthalmic drug Market, by Drug Class, 2016-2026 (K Units) 88
      7. 6.5.7. Europe Ophthalmic drug Market, by Disease Indication, 2016-2026 89
        1. 6.5.7.1. Europe Ophthalmic drug Market, by Disease Indication, 2016-2026 (USD Million) 89
        2. 6.5.7.2. Europe Ophthalmic drug Market, by Disease Indication, 2016-2026 (K Units) 89
      8. 6.5.8. Europe Ophthalmic drug Market, by Distribution Channel, 2016-2026 91
        1. 6.5.8.1. Europe Ophthalmic drug Market, by Distribution Channel, 2016-2026 (USD Million) 91
        2. 6.5.8.2. Europe Ophthalmic drug Market, by Distribution Channel, 2016-2026 (K Units) 91
      9. 6.5.9. Germany 93
        1. 6.5.9.1. Germany Market size and forecast, 2016-2026 (USD Million) 93
        2. 6.5.9.2. Germany Market size and forecast, 2016-2026 (K Units) 94
      10. 6.5.10. France 95
        1. 6.5.10.1. France Market size and forecast, 2016-2026 (USD Million) 95
        2. 6.5.10.2. France Market size and forecast, 2016-2026 (K Units) 96
      11. 6.5.11. U.K. 97
        1. 6.5.11.1. U.K. Market size and forecast, 2016-2026 (USD Million) 97
        2. 6.5.11.2. U.K. Market size and forecast, 2016-2026 (K Units) 98
      12. 6.5.12. Italy 99
        1. 6.5.12.1. Italy Market size and forecast, 2016-2026 (USD Million) 99
        2. 6.5.12.2. Italy Market size and forecast, 2016-2026 (K Units) 100
      13. 6.5.13. Spain 101
        1. 6.5.13.1. Spain Market size and forecast, 2016-2026 (USD Million) 101
        2. 6.5.13.2. Spain Market size and forecast, 2016-2026 (K Units) 102
      14. 6.5.14. Rest of Europe 103
        1. 6.5.14.1. Rest of Europe Market size and forecast, 2016-2026 (USD Million) 103
        2. 6.5.14.2. Rest of Europe Market size and forecast, 2016-2026 (K Units) 104
    6. 6.6. Asia Pacific 105
      1. 6.6.1. Asia Pacific Ophthalmic drug Market size and forecast, 2016-2026 105
      2. 6.6.2. Asia Pacific Ophthalmic drug Market, by Country, 2018 - 2025 (USD Million) 105
      3. 6.6.3. Asia Pacific Market size and forecast, 2016-2026 (K Units) 107
      4. 6.6.4. Asia Pacific Ophthalmic drug Market, by Country, 2018 - 2025 (K Units) 107
      5. 6.6.5. Asia Pacific Ophthalmic drug Market, by Type, 2016-2026 109
        1. 6.6.5.1. Asia Pacific Ophthalmic drug Market, by Type, 2016-2026 (USD Million) 109
        2. 6.6.5.2. Asia Pacific Ophthalmic drug Market, by Type, 2016-2026 (K Units) 109
      6. 6.6.6. Asia Pacific Ophthalmic drug Market, by Drug Class, 2016-2026 110
        1. 6.6.6.1. Asia Pacific Ophthalmic drug Market, by Drug Class, 2016-2026 (USD Million) 110
        2. 6.6.6.2. Asia Pacific Ophthalmic drug Market, by Drug Class, 2016-2026 (K Units) 110
      7. 6.6.7. Asia Pacific Ophthalmic drug Market, by Disease Indication, 2016-2026 111
        1. 6.6.7.1. Asia Pacific Ophthalmic drug Market, by Disease Indication, 2016-2026 (USD Million) 111
        2. 6.6.7.2. Asia Pacific Ophthalmic drug Market, by Disease Indication, 2016-2026 (K Units) 111
      8. 6.6.8. Asia Pacific Ophthalmic drug Market, by Distribution Channel, 2016-2026 113
        1. 6.6.8.1. Asia Pacific Ophthalmic drug Market, by Distribution Channel, 2016-2026 (USD Million) 113
        2. 6.6.8.2. Asia Pacific Ophthalmic drug Market, by Distribution Channel, 2016-2026 (K Units) 113
      9. 6.6.9. China 115
        1. 6.6.9.1. China Market size and forecast, 2016-2026 (USD Million) 115
        2. 6.6.9.2. China Market size and forecast, 2016-2026 (K Units) 116
      10. 6.6.10. Japan 117
        1. 6.6.10.1. Japan Market size and forecast, 2016-2026 (USD Million) 117
        2. 6.6.10.2. Japan Market size and forecast, 2016-2026 (K Units) 118
      11. 6.6.11. India 119
        1. 6.6.11.1. India Market size and forecast, 2016-2026 (USD Million) 119
        2. 6.6.11.2. India Market size and forecast, 2016-2026 (K Units) 120
      12. 6.6.12. South Korea 121
        1. 6.6.12.1. South Korea Market size and forecast, 2016-2026 (USD Million) 121
        2. 6.6.12.2. South Korea Market size and forecast, 2016-2026 (K Units) 122
      13. 6.6.13. South-East Asia 123
        1. 6.6.13.1. South-East Asia Market size and forecast, 2016-2026 (USD Million) 123
        2. 6.6.13.2. South-East Asia Market size and forecast, 2016-2026 (K Units) 124
      14. 6.6.14. Rest of Asia Pacific 125
        1. 6.6.14.1. Rest of Asia Pacific Market size and forecast, 2016-2026 (USD Million) 125
        2. 6.6.14.2. Rest of Asia Pacific Market size and forecast, 2016-2026 (K Units) 126
    7. 6.7. Latin America 127
      1. 6.7.1. Latin America Ophthalmic drug Market size and forecast, 2016-2026 127
      2. 6.7.2. Latin America Ophthalmic drug Market, by Country, 2018 - 2025 (USD Million) 127
      3. 6.7.3. Latin America Market size and forecast, 2016-2026 (K Units) 129
      4. 6.7.4. Latin America Ophthalmic drug Market, by Country, 2018 - 2025 (K Units) 129
      5. 6.7.5. Latin America Ophthalmic drug Market, by Type, 2016-2026 130
        1. 6.7.5.1. Latin America Ophthalmic drug Market, by Type, 2016-2026 (USD Million) 130
        2. 6.7.5.2. Latin America Ophthalmic drug Market, by Type, 2016-2026 (K Units) 130
      6. 6.7.6. Latin America Ophthalmic drug Market, by Drug Class, 2016-2026 131
        1. 6.7.6.1. Latin America Ophthalmic drug Market, by Drug Class, 2016-2026 (USD Million) 131
        2. 6.7.6.2. Latin America Ophthalmic drug Market, by Drug Class, 2016-2026 (K Units) 131
      7. 6.7.7. Latin America Ophthalmic drug Market, by Disease Indication, 2016-2026 132
        1. 6.7.7.1. Latin America Ophthalmic drug Market, by Disease Indication, 2016-2026 (USD Million) 132
        2. 6.7.7.2. Latin America Ophthalmic drug Market, by Disease Indication, 2016-2026 (K Units) 132
      8. 6.7.8. Latin America Ophthalmic drug Market, by Distribution Channel, 2016-2026 134
        1. 6.7.8.1. Latin America Ophthalmic drug Market, by Distribution Channel, 2016-2026 (USD Million) 134
        2. 6.7.8.2. Latin America Ophthalmic drug Market, by Distribution Channel, 2016-2026 (K Units) 134
      9. 6.7.9. Brazil 136
        1. 6.7.9.1. Brazil Market size and forecast, 2016-2026 (USD Million) 136
        2. 6.7.9.2. Brazil Market size and forecast, 2016-2026 (K Units) 137
      10. 6.7.10. Mexico 138
        1. 6.7.10.1. Mexico Market size and forecast, 2016-2026 (USD Million) 138
        2. 6.7.10.2. Mexico Market size and forecast, 2016-2026 (K Units) 139
      11. 6.7.11. Rest of Latin America 140
        1. 6.7.11.1. Rest of Latin America Market size and forecast, 2016-2026 (USD Million) 140
        2. 6.7.11.2. Rest of Latin America Market size and forecast, 2016-2026 (K Units) 141
    8. 6.8. The Middle-East and Africa 142
      1. 6.8.1. The Middle-East and Africa Ophthalmic drug Market size and forecast, 2016-2026 142
      2. 6.8.2. The Middle-East and Africa Ophthalmic drug Market, by Country, 2018 - 2025 (USD Million) 142
      3. 6.8.3. The Middle-East and Africa Market size and forecast, 2016-2026 (K Units) 144
      4. 6.8.4. The Middle-East and Africa Ophthalmic drug Market, by Country, 2018 - 2025 (K Units) 144
      5. 6.8.5. The Middle-East and Africa Ophthalmic drug Market, by Type, 2016-2026 145
        1. 6.8.5.1. The Middle-East and Africa Ophthalmic drug Market, by Type, 2016-2026 (USD Million) 145
        2. 6.8.5.2. The Middle-East and Africa Ophthalmic drug Market, by Type, 2016-2026 (K Units) 145
      6. 6.8.6. The Middle-East and Africa Ophthalmic drug Market, by Drug Class, 2016-2026 146
        1. 6.8.6.1. The Middle-East and Africa Ophthalmic drug Market, by Drug Class, 2016-2026 (USD Million) 146
        2. 6.8.6.2. The Middle-East and Africa Ophthalmic drug Market, by Drug Class, 2016-2026 (K Units) 146
      7. 6.8.7. The Middle-East and Africa Ophthalmic drug Market, by Disease Indication, 2016-2026 148
        1. 6.8.7.1. The Middle-East and Africa Ophthalmic drug Market, by Disease Indication, 2016-2026 (USD Million) 148
        2. 6.8.7.2. The Middle-East and Africa Ophthalmic drug Market, by Disease Indication, 2016-2026 (K Units) 148
      8. 6.8.8. The Middle-East and Africa Ophthalmic drug Market, by Distribution Channel, 2016-2026 150
        1. 6.8.8.1. The Middle-East and Africa Ophthalmic drug Market, by Distribution Channel, 2016-2026 (USD Million) 150
        2. 6.8.8.2. The Middle-East and Africa Ophthalmic drug Market, by Distribution Channel, 2016-2026 (K Units) 150
      9. 6.8.9. GCC Countries 152
        1. 6.8.9.1. GCC Countries Market size and forecast, 2016-2026 (USD Million) 152
        2. 6.8.9.2. GCC Countries Market size and forecast, 2016-2026 (K Units) 153
      10. 6.8.10. South Africa 154
        1. 6.8.10.1. South Africa Market size and forecast, 2016-2026 (USD Million) 154
        2. 6.8.10.2. South Africa Market size and forecast, 2016-2026 (K Units) 155
      11. 6.8.11. Rest of Middle-East Africa 156
        1. 6.8.11.1. Rest of Middle-East Africa Market size and forecast, 2016-2026 (USD Million) 156
        2. 6.8.11.2. Rest of Middle-East Africa Market size and forecast, 2016-2026 (K Units) 157
  7. CHAPTER 7. Ophthalmic drugProduction, Consumption, Export, Import by Regions 158
    1. 7.1. Global Ophthalmic drug production and revenue, 2015-2025 (USD Million) (K Units) 158
    2. 7.2. Global Import and Export Analysis, by Region 162
  8. CHAPTER 8. Ophthalmic drug market – Competitive Landscape 164
    1. 8.1. Competitor Market Share – Revenue 164
    2. 8.2. Market Concentration Rate Analysis, Top 3 and Top 5 Players 166
    3. 8.3. Competitor Market Share – Volume 167
    4. 8.4. Strategic Development 169
      1. 8.4.1. Acquisitions and Mergers 169
      2. 8.4.2. New Products 169
      3. 8.4.3. Research & Development Activities 169
  9. CHAPTER 9. Company Profiles 170
    1. 9.1. Santen Pharmaceutical Co. Ltd. 170
      1. 9.1.1. Company Overview 170
      2. 9.1.2. Santen Pharmaceutical Co. Ltd. Sales, Revenue, Price, and Gross Margin 170
      3. 9.1.3. Product portfolio 171
      4. 9.1.4. Recent initiatives 171
    2. 9.2. Bayer AG 171
      1. 9.2.1. Company Overview 172
      2. 9.2.2. Bayer AG Sales, Revenue, Price, and Gross Margin 172
      3. 9.2.3. Product portfolio 173
      4. 9.2.4. Recent initiatives 173
    3. 9.3. ALLERGAN 173
      1. 9.3.1. Company Overview 174
      2. 9.3.2. ALLERGAN Sales, Revenue, Price, and Gross Margin 174
      3. 9.3.3. Product portfolio 175
      4. 9.3.4. Recent initiatives 175
    4. 9.4. Novartis AG 175
      1. 9.4.1. Company Overview 176
      2. 9.4.2. Novartis AG Sales, Revenue, Price, and Gross Margin 176
      3. 9.4.3. Product portfolio 177
      4. 9.4.4. Recent initiatives 177
    5. 9.5. Pfizer Inc. 177
      1. 9.5.1. Company Overview 178
      2. 9.5.2. Pfizer Inc. Sales, Revenue, Price, and Gross Margin 178
      3. 9.5.3. Product portfolio 179
      4. 9.5.4. Recent initiatives 179
    6. 9.6. Genentech Inc. 179
      1. 9.6.1. Company Overview 180
      2. 9.6.2. Genentech Inc. Sales, Revenue, Price, and Gross Margin 180
      3. 9.6.3. Product portfolio 181
      4. 9.6.4. Recent initiatives 181
    7. 9.7. Oxurion NV 181
      1. 9.7.1. Company Overview 182
      2. 9.7.2. Oxurion NV Sales, Revenue, Price, and Gross Margin 182
      3. 9.7.3. Product portfolio 183
      4. 9.7.4. Recent initiatives 183
    8. 9.8. Bausch Health Companies Inc. 183
      1. 9.8.1. Company Overview 184
      2. 9.8.2. Bausch Health Companies Inc. Sales, Revenue, Price, and Gross Margin 184
      3. 9.8.3. Product portfolio 185
      4. 9.8.4. Recent initiatives 185
    9. 9.9. Regeneron Pharmaceuticals Inc. 185
      1. 9.9.1. Company Overview 186
      2. 9.9.2. Regeneron Pharmaceuticals Inc. Sales, Revenue, Price, and Gross Margin 186
      3. 9.9.3. Product portfolio 187
      4. 9.9.4. Recent initiatives 187
  10. CHAPTER 10. Ophthalmic drug — Industry Analysis 188
    1. 10.1. Introduction and Taxonomy 188
    2. 10.2. Ophthalmic drug Market – Key Trends 188
      1. 10.2.1. Market Drivers 189
      2. 10.2.2. Market Restraints 189
      3. 10.2.3. Market Opportunities 190
    3. 10.3. Value Chain Analysis 191
    4. 10.4. Key Mandates and Regulations 192
    5. 10.5. Technology Roadmap and Timeline 193
    6. 10.6. Ophthalmic drug market – Attractiveness Analysis 194
      1. 10.6.1. By Type 194
      2. 10.6.2. By Drug Class 194
      3. 10.6.3. By Disease Indication 195
      4. 10.6.4. By Distribution Channel 196
      5. 10.6.5. By Region 197
  11. CHAPTER 11. Raw Material analysis 198
    1. 11.1. Ophthalmic drug Key Raw Material Analysis 198
      1. 11.1.1. Key Raw Materials 198
      2. 11.1.2. Price Trend of Key Raw Materials 198
    2. 11.2. Key Suppliers of Raw Materials 200
    3. 11.3. Proportion of Manufacturing Cost Structure 200
      1. 11.3.1. Raw Materials 201
      2. 11.3.2. Labor Cost 201
    4. 11.4. Manufacturing Expenses Analysis of Ophthalmic drug 201
  12. CHAPTER 12. Industrial Chain, Sourcing Strategy and Downstream Buyers 202
    1. 12.1. Ophthalmic drug Industrial Chain Analysis 202
    2. 12.2. Upstream Raw Materials Sourcing 203
      1. 12.2.1. Risk Mitigation: 203
      2. 12.2.2. Supplier Relationships: 203
      3. 12.2.3. Business Processes: 203
      4. 12.2.4. Securing the Product: 203
    3. 12.3. Raw Materials Sources of Ophthalmic drug Major Manufacturers in 2016 203
    4. 12.4. Downstream Buyers 203
    5. 12.5. Distributors/Traders List 204
  13. CHAPTER 13. Marketing Strategy Analysis, Distributors 205
    1. 13.1. Marketing Channel 205
    2. 13.2. Direct Marketing 206
    3. 13.3. Indirect Marketing 206
    4. 13.4. Marketing Channel Development Trend 206
    5. 13.5. Economic/Political Environmental Change 207
  14. CHAPTER 14. Report Conclusion 208
  15. CHAPTER 15. Research Approach & Methodology 209
    1. 15.1. Report Description 209
    2. 15.2. Research Scope 210
    3. 15.3. Research Methodology 210
      1. 15.3.1. Secondary Research 211
      2. 15.3.2. Primary Research 212
      3. 15.3.3. Models 213
        1. 15.3.3.1. Company Share Analysis Model 213
        2. 15.3.3.2. Revenue Based Modeling 214
        3. 15.3.3.3. Research Limitations 214

        List of Figures

        FIG. 1    Global Ophthalmic drug Market, 2016-2026 (USD Million)    29
        FIG. 2    Global Ophthalmic drug Market Share, by Type, 2018 & 2025 (USD Million)    30
        FIG. 3    Global Ophthalmic drug Market share, by Type, 2018 & 2025 (K Units)    32
        FIG. 4    Global Over-the-Counter Drugs Ophthalmic drug Market, 2016-2026 (USD Million)    33
        FIG. 5    Global Over-the-Counter Drugs Ophthalmic drug  Market, 2016-2026 (K Units)    34
        FIG. 6    Global Prescription Drugs Ophthalmic drug Market, 2016-2026 (USD Million)    35
        FIG. 7    Global Prescription Drugs Ophthalmic drug  Market, 2016-2026 (K Units)    36
        FIG. 8    Global Ophthalmic drug Market Share, by Drug Class, 2018 & 2025 (USD Million)    36
        FIG. 9    Global Ophthalmic drug Market share, by Drug Class, 2018 & 2025 (K Units)    38
        FIG. 10    Global Anti-Infective Drugs Ophthalmic drug Market, 2016-2026 (USD Million)    39
        FIG. 11    Global Anti-Infective Drugs Ophthalmic drug  Market, 2016-2026 (K Units)    40
        FIG. 12    Global Anti-Glaucoma Drugs Ophthalmic drug Market, 2016-2026 (USD Million)    41
        FIG. 13    Global Anti-Glaucoma Drugs Ophthalmic drug  Market, 2016-2026 (K Units)    42
        FIG. 14    Global Anti-inflammatory Drugs Ophthalmic drug Market, 2016-2026 (USD Million)    43
        FIG. 15    Global Anti-inflammatory Drugs Ophthalmic drug  Market, 2016-2026 (K Units)    44
        FIG. 16    Global Anti-Allergic Drugs Ophthalmic drug Market, 2016-2026 (USD Million)    45
        FIG. 17    Global Anti-Allergic Drugs Ophthalmic drug  Market, 2016-2026 (K Units)    46
        FIG. 18    Global Ophthalmic drug Market Share, by Disease Indication, 2018 & 2025 (USD Million)    46
        FIG. 19    Global Ophthalmic drug Market share, by Disease Indication, 2018 & 2025 (K Units)    48
        FIG. 20    Global Inflammation/ Infection Ophthalmic drug Market, 2016-2026 (USD Million)    49
        FIG. 21    Global Inflammation/ Infection Ophthalmic drug  Market, 2016-2026 (K Units)    50
        FIG. 22    Global Retinal Disorders Ophthalmic drug Market, 2016-2026 (USD Million)    51
        FIG. 23    Global Retinal Disorders Ophthalmic drug  Market, 2016-2026 (K Units)    52
        FIG. 24    Global Dry Eye Ophthalmic drug Market, 2016-2026 (USD Million)    53
        FIG. 25    Global Dry Eye Ophthalmic drug  Market, 2016-2026 (K Units)    54
        FIG. 26    Global Glaucoma Ophthalmic drug Market, 2016-2026 (USD Million)    55
        FIG. 27    Global Glaucoma Ophthalmic drug  Market, 2016-2026 (K Units)    56
        FIG. 28    Global Allergies Ophthalmic drug Market, 2016-2026 (USD Million)    57
        FIG. 29    Global Allergies Ophthalmic drug  Market, 2016-2026 (K Units)    58
        FIG. 30    Global Others Ophthalmic drug Market, 2016-2026 (USD Million)    59
        FIG. 31    Global Others Ophthalmic drug  Market, 2016-2026 (K Units)    60
        FIG. 32    Global Ophthalmic drug Market Share, by Distribution Channel, 2018 & 2025 (USD Million)    60
        FIG. 33    Global Ophthalmic drug Market share, by Distribution Channel, 2018 & 2025 (K Units)    62
        FIG. 34    Global Online Sales Ophthalmic drug Market, 2016-2026 (USD Million)    63
        FIG. 35    Global Online Sales Ophthalmic drug  Market, 2016-2026 (K Units)    64
        FIG. 36    Global Retail Pharmacies Ophthalmic drug Market, 2016-2026 (USD Million)    65
        FIG. 37    Global Retail Pharmacies Ophthalmic drug  Market, 2016-2026 (K Units)    66
        FIG. 38    Global Hospital Pharmacies Ophthalmic drug Market, 2016-2026 (USD Million)    67
        FIG. 39    Global Hospital Pharmacies Ophthalmic drug  Market, 2016-2026 (K Units)    68
        FIG. 40    Global Others Ophthalmic drug Market, 2016-2026 (USD Million)    69
        FIG. 41    Global Others Ophthalmic drug  Market, 2016-2026 (K Units)    70
        FIG. 42    Global Ophthalmic drug Market Share, by Region, 2018 & 2025    71
        FIG. 43    Global Ophthalmic drug Market Share, by Region, 2018 & 2025    73
        FIG. 44    North America Ophthalmic drug Market, 2016-2026    74
        FIG. 45    North America Ophthalmic drug  Market, 2016-2026 (K Units)    75
        FIG. 46    U.S. Ophthalmic drug Market, 2016-2026    82
        FIG. 47    U.S. Ophthalmic drug  Market, 2016-2026 (K Units)    83
        FIG. 48    Canada Ophthalmic drug Market, 2016-2026    84
        FIG. 49    Canada Ophthalmic drug  Market, 2016-2026 (K Units)    85
        FIG. 50    Europe Ophthalmic drug Market, 2016-2026    86
        FIG. 51    Europe Ophthalmic drug  Market, 2016-2026 (K Units)    88
        FIG. 52    Germany Ophthalmic drug Market, 2016-2026    96
        FIG. 53    Germany Ophthalmic drug  Market, 2016-2026 (K Units)    97
        FIG. 54    France Ophthalmic drug Market, 2016-2026    98
        FIG. 55    France Ophthalmic drug  Market, 2016-2026 (K Units)    99
        FIG. 56    U.K. Ophthalmic drug Market, 2016-2026    100
        FIG. 57    U.K. Ophthalmic drug  Market, 2016-2026 (K Units)    101
        FIG. 58    Italy Ophthalmic drug Market, 2016-2026    102
        FIG. 59    Italy Ophthalmic drug  Market, 2016-2026 (K Units)    103
        FIG. 60    Spain Ophthalmic drug Market, 2016-2026    104
        FIG. 61    Spain Ophthalmic drug  Market, 2016-2026 (K Units)    105
        FIG. 62    Rest of Europe Ophthalmic drug Market, 2016-2026    106
        FIG. 63    Rest of Europe Ophthalmic drug  Market, 2016-2026 (K Units)    107
        FIG. 64    Asia Pacific Ophthalmic drug Market, 2016-2026    108
        FIG. 65    Asia Pacific Ophthalmic drug  Market, 2016-2026 (K Units)    110
        FIG. 66    China Ophthalmic drug Market, 2016-2026    118
        FIG. 67    China Ophthalmic drug  Market, 2016-2026 (K Units)    119
        FIG. 68    Japan Ophthalmic drug Market, 2016-2026    120
        FIG. 69    Japan Ophthalmic drug  Market, 2016-2026 (K Units)    121
        FIG. 70    India Ophthalmic drug Market, 2016-2026    122
        FIG. 71    India Ophthalmic drug  Market, 2016-2026 (K Units)    123
        FIG. 72    South  Korea Ophthalmic drug Market, 2016-2026    124
        FIG. 73    South  Korea Ophthalmic drug  Market, 2016-2026 (K Units)    125
        FIG. 74    South-East Asia Ophthalmic drug Market, 2016-2026    126
        FIG. 75    South-East Asia Ophthalmic drug  Market, 2016-2026 (K Units)    127
        FIG. 76    Rest of Asia Pacific Ophthalmic drug Market, 2016-2026    128
        FIG. 77    Rest of Asia Pacific Ophthalmic drug  Market, 2016-2026 (K Units)    129
        FIG. 78    Latin America Ophthalmic drug Market, 2016-2026    130
        FIG. 79    Latin America Ophthalmic drug  Market, 2016-2026 (K Units)    132
        FIG. 80    Brazil Ophthalmic drug Market, 2016-2026    139
        FIG. 81    Brazil Ophthalmic drug  Market, 2016-2026 (K Units)    140
        FIG. 82    Mexico Ophthalmic drug Market, 2016-2026    141
        FIG. 83    Mexico Ophthalmic drug  Market, 2016-2026 (K Units)    142
        FIG. 84    Rest of Latin America Ophthalmic drug Market, 2016-2026    143
        FIG. 85    Rest of Latin America Ophthalmic drug  Market, 2016-2026 (K Units)    144
        FIG. 86    The Middle-East and Africa Ophthalmic drug Market, 2016-2026    145
        FIG. 87    The Middle-East and Africa Ophthalmic drug  Market, 2016-2026 (K Units)    147
        FIG. 88    GCC Countries Ophthalmic drug Market, 2016-2026    155
        FIG. 89    GCC Countries Ophthalmic drug  Market, 2016-2026 (K Units)    156
        FIG. 90    South Africa Ophthalmic drug Market, 2016-2026    157
        FIG. 91    South Africa Ophthalmic drug  Market, 2016-2026 (K Units)    158
        FIG. 92    Rest of Middle-East Africa Ophthalmic drug Market, 2016-2026    159
        FIG. 93    Rest of Middle-East Africa Ophthalmic drug  Market, 2016-2026 (K Units)    160
        FIG. 94    Global Ophthalmic drug production and revenue, 2015-2025 (USD Million) (K Units)    161
        FIG. 95    North America Ophthalmic drug production and revenue, 2015-2025 (USD Million) (K Units)    162
        FIG. 96    Europe Ophthalmic drug production and revenue, 2015-2025 (USD Million) (K Units)    162
        FIG. 97    Asia Pacific Ophthalmic drug production and revenue, 2015-2025 (USD Million) (K Units)    163
        FIG. 98    Latin America Ophthalmic drug production and revenue, 2015-2025 (USD Million) (K Units)    163
        FIG. 99    Middle East and Africa Ophthalmic drug production and revenue, 2015-2025 (USD Million) (K Units)    164
        FIG. 100    Competitor Market Share – Revenue    167
        FIG. 101    Competitor Market Share – Volume    170
        FIG. 102    Santen Pharmaceutical Co. Ltd. Revenue and Growth Rate    174
        FIG. 103    Santen Pharmaceutical Co. Ltd. Market Share    174
        FIG. 104    Bayer AG Revenue and Growth Rate    176
        FIG. 105    Bayer AG Market Share    176
        FIG. 106    ALLERGAN Revenue and Growth Rate    178
        FIG. 107    ALLERGAN Market Share    178
        FIG. 108    Novartis AG Revenue and Growth Rate    180
        FIG. 109    Novartis AG Market Share    180
        FIG. 110    Pfizer Inc. Revenue and Growth Rate    182
        FIG. 111    Pfizer Inc. Market Share    182
        FIG. 112    Genentech Inc. Revenue and Growth Rate    184
        FIG. 113    Genentech Inc. Market Share    184
        FIG. 114    Oxurion NV Revenue and Growth Rate    186
        FIG. 115    Oxurion NV Market Share    186
        FIG. 116    Bausch Health Companies Inc. Revenue and Growth Rate    188
        FIG. 117    Bausch Health Companies Inc. Market Share    188
        FIG. 118    Regeneron Pharmaceuticals Inc. Revenue and Growth Rate    190
        FIG. 119    Regeneron Pharmaceuticals Inc. Market Share    190
        FIG. 120    Market Dynamics    191
        FIG. 121    Global Ophthalmic drug – Value Chain Analysis    194
        FIG. 122    Key Mandates and Regulations    195
        FIG. 123    Technology Roadmap and Timeline    196
        FIG. 124    Market Attractiveness Analysis – By Type    197
        FIG. 125    Market Attractiveness Analysis – By Drug Class    198
        FIG. 126    Market Attractiveness Analysis – By Disease Indication    198
        FIG. 127    Market Attractiveness Analysis – By Distribution Channel    199
        FIG. 128    Market Attractiveness Analysis – By Region    200
        FIG. 129    Manufacturing Cost Structure of Ophthalmic drug    203
        FIG. 130    Ophthalmic drug Industrial Chain Analysis    205
        FIG. 131    Market Channel    208
        FIG. 132    Marketing Channel Development Trend    209
        FIG. 133    Growth in World Gross Product, 2008-2018    210


        List of Tables

        TABLE 1    Global Ophthalmic drug market, 2018 & 2025 (USD Million)    29
        TABLE 2    Global Ophthalmic drug market, by Type, 2016-2026 (USD Million)    32
        TABLE 3    Global Ophthalmic drug market, by Type, 2016-2026 (K Units)    34
        TABLE 4    Global Ophthalmic drug market, by Drug Class, 2016-2026 (USD Million)    39
        TABLE 5    Global Ophthalmic drug market, by Drug Class, 2016-2026 (K Units)    40
        TABLE 6    Global Ophthalmic drug market, by Disease Indication, 2016-2026 (USD Million)    49
        TABLE 7    Global Ophthalmic drug market, by Disease Indication, 2016-2026 (K Units)    50
        TABLE 8    Global Ophthalmic drug market, by Distribution Channel, 2016-2026 (USD Million)    63
        TABLE 9    Global Ophthalmic drug market, by Distribution Channel, 2016-2026 (K Units)    64
        TABLE 10    Global Ophthalmic drug market, by region, 2016-2026 (USD Million)    73
        TABLE 11    Global Ophthalmic drug market, by region, 2016-2026 (K Units)    75
        TABLE 12    North America Ophthalmic drug Market, by Type, 2016-2026 (USD Million)    78
        TABLE 13    North America Ophthalmic drug Market, by Type, 2016-2026 (K Units)    78
        TABLE 14    North America Ophthalmic drug Market, by Drug Class, 2016-2026 (USD Million)    79
        TABLE 15    North America Ophthalmic drug Market, by Drug Class, 2016-2026 (K Units)    79
        TABLE 16    North America Ophthalmic drug Market, by Disease Indication, 2016-2026 (USD Million)    80
        TABLE 17    North America Ophthalmic drug Market, by Disease Indication, 2016-2026 (K Units)    80
        TABLE 18    North America Ophthalmic drug Market, by Distribution Channel, 2016-2026 (USD Million)    82
        TABLE 19    North America Ophthalmic drug Market, by Distribution Channel, 2016-2026 (K Units)    82
        TABLE 20    Europe Ophthalmic drug Market, by Type, 2016-2026 (USD Million)    92
        TABLE 21    Europe Ophthalmic drug Market, by Type, 2016-2026 (K Units)    92
        TABLE 22    Europe Ophthalmic drug Market, by Drug Class, 2016-2026 (USD Million)    93
        TABLE 23    Europe Ophthalmic drug Market, by Drug Class, 2016-2026 (K Units)    93
        TABLE 24    Europe Ophthalmic drug Market, by Disease Indication, 2016-2026 (USD Million)    94
        TABLE 25    Europe Ophthalmic drug Market, by Disease Indication, 2016-2026 (K Units)    94
        TABLE 26    Europe Ophthalmic drug Market, by Distribution Channel, 2016-2026 (USD Million)    96
        TABLE 27    Europe Ophthalmic drug Market, by Distribution Channel, 2016-2026 (K Units)    96
        TABLE 28    Asia Pacific Ophthalmic drug Market, by Type, 2016-2026 (USD Million)    114
        TABLE 29    Asia Pacific Ophthalmic drug Market, by Type, 2016-2026 (K Units)    114
        TABLE 30    Asia Pacific Ophthalmic drug Market, by Drug Class, 2016-2026 (USD Million)    115
        TABLE 31    Asia Pacific Ophthalmic drug Market, by Drug Class, 2016-2026 (K Units)    115
        TABLE 32    Asia Pacific Ophthalmic drug Market, by Disease Indication, 2016-2026 (USD Million)    116
        TABLE 33    Asia Pacific Ophthalmic drug Market, by Disease Indication, 2016-2026 (K Units)    116
        TABLE 34    Asia Pacific Ophthalmic drug Market, by Distribution Channel, 2016-2026 (USD Million)    118
        TABLE 35    Asia Pacific Ophthalmic drug Market, by Distribution Channel, 2016-2026 (K Units)    118
        TABLE 36    Latin America Ophthalmic drug Market, by Type, 2016-2026 (USD Million)    135
        TABLE 37    Latin America Ophthalmic drug Market, by Type, 2016-2026 (K Units)    135
        TABLE 38    Latin America Ophthalmic drug Market, by Drug Class, 2016-2026 (USD Million)    136
        TABLE 39    Latin America Ophthalmic drug Market, by Drug Class, 2016-2026 (K Units)    136
        TABLE 40    Latin America Ophthalmic drug Market, by Disease Indication, 2016-2026 (USD Million)    137
        TABLE 41    Latin America Ophthalmic drug Market, by Disease Indication, 2016-2026 (K Units)    137
        TABLE 42    Latin America Ophthalmic drug Market, by Distribution Channel, 2016-2026 (USD Million)    139
        TABLE 43    Latin America Ophthalmic drug Market, by Distribution Channel, 2016-2026 (K Units)    139
        TABLE 44    The Middle-East and Africa Ophthalmic drug Market, by Type, 2016-2026 (USD Million)    150
        TABLE 45    The Middle-East and Africa Ophthalmic drug Market, by Type, 2016-2026 (K Units)    150
        TABLE 46    The Middle-East and Africa Ophthalmic drug Market, by Drug Class, 2016-2026 (USD Million)    151
        TABLE 47    The Middle-East and Africa Ophthalmic drug Market, by Drug Class, 2016-2026 (K Units)    151
        TABLE 48    The Middle-East and Africa Ophthalmic drug Market, by Disease Indication, 2016-2026 (USD Million)    153
        TABLE 49    The Middle-East and Africa Ophthalmic drug Market, by Disease Indication, 2016-2026 (K Units)    153
        TABLE 50    The Middle-East and Africa Ophthalmic drug Market, by Distribution Channel, 2016-2026 (USD Million)    155
        TABLE 51    The Middle-East and Africa Ophthalmic drug Market, by Distribution Channel, 2016-2026 (K Units)    155
        TABLE 52    North America Ophthalmic drug Production, Consumption, Export, Import, 2016-2019    167
        TABLE 53    Europe Ophthalmic drug Production, Consumption, Export, Import, 2016-2019    167
        TABLE 54    Asia Pacific Ophthalmic drug Production, Consumption, Export, Import, 2016-2019    167
        TABLE 55    Latin America Ophthalmic drug Production, Consumption, Export, Import, 2016-2019    168
        TABLE 56    Middle East & Africa Ophthalmic drug Production, Consumption, Export, Import, 2016-2019    168
        TABLE 57    Global Ophthalmic drug Market - Company Revenue Analysis 2016-2019 (USD Million)    169
        TABLE 58    Global Ophthalmic drug Market - Company Revenue Share Analysis 2016-2019(%)    171
        TABLE 59    Global Ophthalmic drug Market - Company Volume Analysis 2016-2019 (K Units)    172
        TABLE 60    Global Ophthalmic drug Market - Company Volume Share Analysis 2016-2019(%)    173
        TABLE 61    Acquisitions and Mergers    174
        TABLE 62    New Product/Service Launch    174
        TABLE 63    Research & Development Activities    174
        TABLE 64    Market Drivers    194
        TABLE 65    Market Restraints    194
        TABLE 66    Market Opportunities    195
        TABLE 67    Production Base and Market Concentration Rate of Raw Material    203
        TABLE 68    Key Suppliers of Raw Materials    205
        TABLE 69    Raw Materials Sources of Ophthalmic drug Major Manufacturers in 2016    208
        TABLE 70    Major Buyers of Ophthalmic drug    208
        TABLE 71    Distributors/Traders of Ophthalmic drug by Region    209

Key Insights from Primary Research

  • The increasing ocular disease-relatedincidences are propelling the global ophthalmic drug market, according to the primary respondents.
  • The increase in R&D and drug discovery activities in the pharmaceutical sector from the past several years has significantly boosted the ophthalmic drug market.
  • In some cases, the ophthalmic drugs react and cause severe side effects including irritation and blurred vision, thereby impeding the drug market.
  • Novel and effective discovery of ophthalmic drugs is a laborious process owing to the stringent guidelines set by the FDA and other regulatory bodies, which eventually hampers the global market growth.
  • The primary respondents stated that anti-infective drugs have been contributing significantly to the global market, capturing over one-third of the market share in terms of revenue and unit sales.

Key Recommendations from Analysts

  • Based on the analytical data, the global ophthalmic market generated a revenue of over USD 27,000 million in 2019 and is projected to reach the value close to USD 37,700 million propelling at a rate of around 4.6%.
  • According to analysts, the cases of ophthalmic disorders are rising considerably due to the increasing environmental pollution, especially air & water, which in turn flourishes the global ophthalmic drug market.
  • Analysts indicated that North America dominated the global ophthalmic market holding over 40% market share in terms of revenue and volume.
  • The drugs associated with “retinal disorders” category under the disease indication segment accounts for around one-third of the global ophthalmic market share.
  • Hospital pharmacies generate considerably higher revenue through ophthalmic drug sales. However, analysts have indicated that the retail pharmacies category is anticipated to grow at a faster rate.

Global Ophthalmic Drug Market Attractiveness in 2018- By Region

Global Ophthalmic Drug Market

Industry Major Market Players

  • Santen Pharmaceutical Co. Ltd.
  • Bayer AG
  • ALLERGAN
  • Novartis AG
  • Pfizer Inc.
  • Genentech Inc.
  • Oxurion NV
  • Bausch Health Companies Inc.
  • Regeneron Pharmaceuticals Inc.  

Safe and Secure SSL Encrypted

Choose License Type

Inquiry For Buying
have a question

HAVE A QUESTION? Executive will help you find what you are looking for.


REQUEST CUSTOMIZATION

Still haven't found what you're looking for? Speak to our Custom Research Team

Learn More
Facts & Factors provides an array of marketing and business research solutions distinctly designed by our expertise for the clients.
Copyright © 2020 Facts & Factors. All Rights Reserved. Sitemap - Privacy Policy - Terms & Conditions